Role of K63-linked ubiquitination in cancer
Open Access
- 6 October 2022
- journal article
- review article
- Published by Springer Nature in Cell Death Discovery
- Vol. 8 (1) , 1-13
Abstract
Ubiquitination is a critical type of post-translational modifications, of which K63-linked ubiquitination regulates interaction, translocation, and activation of proteins. In recent years, emerging evidence suggest involvement of K63-linked ubiquitination in multiple signaling pathways and various human diseases including cancer. Increasing number of studies indicated that K63-linked ubiquitination controls initiation, development, invasion, metastasis, and therapy of diverse cancers. Here, we summarized molecular mechanisms of K63-linked ubiquitination dictating different biological activities of tumor and highlighted novel opportunities for future therapy targeting certain regulation of K63-linked ubiquitination in tumor.Keywords
Funding Information
- National Natural Science Foundation of China (82102740)
- Natural Science Foundation of Liaoning Province (2019-ZD-0748)
This publication has 226 references indexed in Scilit:
- Deubiquitination of Dishevelled by Usp14 is required for Wnt signalingOncogenesis, 2013
- Opposing Effect of EGFRWT on EGFRvIII-Mediated NF-κB Activation with RIP1 as a Cell Death SwitchCell Reports, 2013
- MicroRNAs miR-125a and miR-125b constitutively activate the NF-κB pathway by targeting the tumor necrosis factor alpha-induced protein 3 ( TNFAIP3, A20 )Proceedings of the National Academy of Sciences, 2012
- Skp2 E3 Ligase Integrates ATM Activation and Homologous Recombination Repair by Ubiquitinating NBS1Molecular Cell, 2012
- Tumor Metastasis: Molecular Insights and Evolving ParadigmsCell, 2011
- Recent Advances in NeuroblastomaNew England Journal of Medicine, 2010
- The RING Domain of TRAF2 Plays an Essential Role in the Inhibition of TNFα-Induced Cell Death but Not in the Activation of NF-κBJournal of Molecular Biology, 2010
- The DNA-damage response in human biology and diseaseNature, 2009
- Inactivation of the CYLD Deubiquitinase by HPV E6 Mediates Hypoxia-Induced NF-κB ActivationCancer Cell, 2008
- Alternative UPS drug targets upstream the 26S proteasomeThe International Journal of Biochemistry & Cell Biology, 2008